Suppr超能文献

新型胞外ATP酶选择性抑制剂FPL 67156的药理与生化分析

Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase.

作者信息

Crack B E, Pollard C E, Beukers M W, Roberts S M, Hunt S F, Ingall A H, McKechnie K C, IJzerman A P, Leff P

机构信息

Department of Pharmacology, Fisons R&D Labs, Loughborough, Leicestershire.

出版信息

Br J Pharmacol. 1995 Jan;114(2):475-81. doi: 10.1111/j.1476-5381.1995.tb13251.x.

Abstract
  1. FPL 67156 (6-N,N-diethyl-beta, gamma-dibromomethylene-D-ATP), is a newly synthesized analogue of ATP. 2. In a rabbit isolated tracheal epithelium preparation, measuring P2U-purinoceptor-dependent chloride secretion, FPL 67156 was discovered to potentiate the responses to UTP but not those to ATP-gamma-S. UTP agonist-concentration effect (E/[A]) curves were shifted to the left by 5-fold in the presence of 100 microM FPL 67156. The differential effect of FPL 67156 on UTP and ATP-gamma-S was hypothesized to be due to the greater susceptibility of UTP to enzymatic dephosphorylation and the ability of FPL 67156 to inhibit this process. 3. FPL 67156 was tested as an ecto-ATPase inhibitor in a human blood cell assay, measuring [gamma 32P]-ATP dephosphorylation. The compound inhibited [gamma 32P]-ATP degradation with a pIC50 of 4.6. 4. FPL 67156 was then tested for its effects on ATP and alpha, beta-methylene-ATP responses at P2X-purinoceptors in the rabbit isolated ear artery. In the concentration range 30 microM-1 mM, the compound potentiated the contractile effects of ATP but not those of alpha, beta-methylene-ATP. At 1 mM, FPL 67156 produced a 34-fold leftward shift of ATP E/[A] curves. 5. The effects of FPL 67156 on ATP E/[A] curves in the rabbit ear artery were analyzed using a theoretical model (Furchgott, 1972) describing the action of an enzyme inhibitor on the effects of a metabolically unstable agonist. This analysis provided an estimate of the pKi for FPL 67156 as an ecto-ATPase inhibitor of 5.2. 6. Using appropriate assays, FPL 67156 was shown to have weak antagonist effects at P2X- and P2T-purinoceptors (pA2 ~ 3.3 and 3.5 respectively), and weak agonist effects at P2u-purinoceptors(p[A 50]~ 3.5).7. The degree of potentiation of ATP and UTP effects elicited by FPL 67156 confirms previous results concerning the influence that ecto-ATPase has on the position of E/[A] curves for metabolically unstable agonists. The magnitude of this influence is predicted to have a major effect on the agonist potency orders currently used to designate purinoceptors.8.This study indicates FPL 67156 to be a potentially valuable probe in studies on the action of nucleotides and in the classification of purinoceptors.
摘要
  1. FPL 67156(6 - N,N - 二乙基 - β,γ - 二溴亚甲基 - D - ATP)是一种新合成的ATP类似物。2. 在兔离体气管上皮制备物中,通过测量P2U嘌呤受体依赖性氯离子分泌,发现FPL 67156可增强对UTP的反应,但对ATP - γ - S的反应无增强作用。在存在100 microM FPL 67156的情况下,UTP激动剂浓度效应(E/[A])曲线向左移动了5倍。推测FPL 67156对UTP和ATP - γ - S的不同作用是由于UTP对酶促去磷酸化的敏感性更高以及FPL 67156抑制该过程的能力。3. 在人血细胞测定中,通过测量[γ32P] - ATP的去磷酸化,对FPL 67156作为胞外ATP酶抑制剂进行了测试。该化合物抑制[γ32P] - ATP降解,pIC50为4.6。4. 然后在兔离体耳动脉中测试FPL 67156对P2X嘌呤受体处ATP和α,β - 亚甲基 - ATP反应的影响。在30 microM - 1 mM的浓度范围内,该化合物增强了ATP的收缩作用,但对α,β - 亚甲基 - ATP的收缩作用无增强作用。在1 mM时,FPL 67156使ATP E/[A]曲线向左移动了34倍。5. 使用描述酶抑制剂对代谢不稳定激动剂作用的理论模型(Furchgott,1972)分析了FPL 67156对兔耳动脉中ATP E/[A]曲线的影响。该分析得出FPL 67156作为胞外ATP酶抑制剂的pKi估计值为5.2。6. 通过适当的测定方法,表明FPL 67156在P2X和P2T嘌呤受体处具有弱拮抗作用(pA2分别约为3.3和3.5),在P2u嘌呤受体处具有弱激动作用(p[A50]约为3.5)。7. FPL 67156引起的ATP和UTP效应增强程度证实了先前关于胞外ATP酶对代谢不稳定激动剂E/[A]曲线位置影响的结果。预计这种影响的大小对目前用于指定嘌呤受体的激动剂效力顺序有重大影响。8. 本研究表明FPL 67156在核苷酸作用研究和嘌呤受体分类中是一种潜在有价值的探针。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验